Collaborations

 

Omar Akbari-3 Omar Akbari

Omar Akbari, PhD, received bachelor’s, master’s and doctoral degrees from the University of Nevada, Reno and conducted postdoctoral research at the California Institute of Technology in Professor Bruce Hay’s laboratory. His research focuses on the basic genetics and physiology of mosquitoes with the goal of developing innovative, creative, synthetic-biology inspired genetic control technologies for reducing the burden of mosquito-borne diseases on humans. The underlying hypothesis inspiring this work is that the introduction and spread of genes that prevent mosquitoes from transmitting pathogens should, in theory, lead to reduced transmission of these pathogens, resulting in reductions of human infections and death. Prior to joining UC San Diego, he was based at the Center for Infectious Disease and Vector Research at UC Riverside. In collaboration with TIGS, Akbari is working toward  developing active genetic elements and systems in mosquitoes.

 

Geoffrey Chang Geoffrey Chang

Geoffrey Chang, PhD, is a professor in the Skaggs School of Pharmacy and Pharmaceutical Sciences in the Department of Pharmacology at UC San Diego. He received his B.A. and M.S. in biophysics and his Ph.D. in molecular biophysics from the University of Pennsylvania, after which he completed postdoctoral training at the California Institute of Technology. His lab focuses on the structural biology of transporters. In his collaboration with TIGS, he is utilizing a camelid nanobody screening technology pioneered in his lab to help identify better effectors against the human malaria parasites Plasmodium falciparum and Plasmodium vivax.

 

Kim Cooper-2 Kimberly Cooper

Kimberly Cooper, PhD, completed her doctoral degree at the Fred Hutchinson Cancer Research Center in Seattle, Wash., followed by postdoctoral studies in the Department of Genetics at Harvard Medical School. She joined the Division of Biological Sciences faculty at UC San Diego in November 2013, and her research is focused on the relationship between gene regulatory landscapes and phenotypic malleability in jerboa limb development. In her collaboration with TIGS, she will be exploring the use of Active Genetics in mouse systems.

 

Stephen Hedrick  Stephen Hedrick

Stephen Hedrick received his PhD from the University of California, Irvine, and conducted postdoctoral studies at the National Institutes of Health. He is a Distinguished Professor and holds the Chancellor’s Associates’ Chair in the Biological Sciences with joint appointments in Molecular Biology and Cellular and Molecular Medicine. He has been interested in probing the biology of T cells using mouse genetics for his entire academic career. Most recently, he and colleagues received a Transformative Grant from the NIH to study ways in which Active Genetics can be used to eliminate inhibitory feedback pathways in T cells. The goal of these studies is to generate highly cancer-reactive T cells that can subsequently be controlled by activating a fail-safe, inducible death signal.

 

 Victor Nizet Victor Nizet

Victor Nizet, M.D., is professor and vice chair for basic research in the Department of Pediatrics at UC San Diego, where he is also chief of the Division of Host-Microbe Systems and Therapeutics. He received his undergraduate education at Reed College in Portland, Ore., majoring in biology and completing a senior thesis in evolutionary ecology with Professor Robert Kaplan. He subsequently began his medical training at Stanford University School of Medicine in Palo Alto, Calif., where he was introduced to the science of bacterial pathogenesis as a research assistant in the laboratory of Professor Gary Schoolnik. After graduation, he completed a residency and chief residency in pediatrics at Harvard University's Children's Hospital in Boston, and a fellowship in pediatric infectious diseases at the University of Washington's Children's Hospital in Seattle. The Division of Host-Microbe Systems and Therapeutics brings together a diverse group of scientists and physicians for interdisciplinary research on the interactions of humans and the microbial world in both health and disease. In his collaboration with TIGS, he will be exploring the application of Active Genetics toward the growing problem of bacterial antibiotic resistance.

 

Martin Yanofsky  Martin Yanofsky

Martin Yanofsky, PhD, is a Distinguished Professor and the Paul D. Saltman Endowed Chair in Science Education at UC San Diego. He received his PhD from the University of Washington and was an NSF Postdoctoral Fellow in Plant Biology at Caltech. He was the recipient of a Packard Fellowship for Science and Engineering and a Beckman Young Investigator Award and is a member of the National Academy of Sciences. During the past 27 years at UC San Diego, Prof. Yanofsky’s lab has used the reference plant Arabidopsis thaliana to uncover the underlying mechanisms controlling flower and fruit development as well as stem cell formation. His lab has developed technologies that are currently being used to dramatically increase the yield of food crops. More recently, his lab has been exploring ways to implement Active Genetics technologies in plants, a tool that could have important applications in basic and applied plant science.

 

Vector-borne Disease Consortium

UC San Diego has joined with the University of California, Irvine (UCI) to create the Vector-borne Disease Consortium to promote discovery and development of novel science with the ultimate goal of eradicating mosquito-transmitted diseases in India and Africa. Consortium research is highly collaborative and allows for the sharing of materials, know-how, and brings together experts from molecular biology, entomology, public health, community engagement and regulatory control. Future field trials will adhere to guidelines developed by the World Health Organization, National Academies of Sciences and other regulatory agencies in which a phased approach is used to test both safety and efficacy of mosquito strains as the Consortium’s work progresses.

Related: https://news.uci.edu/research/uci-establishes-malaria-initiative-to-fight-deadly-disease-in-africa/